Precipitation of fibrinogen is a newly described property of streptococcal M protein (1). Heretofore the only known function of M protein has been related to determining virulence of Group A streptococci by impeding phagocytosis (2). Small amounts of M protein have been injected into normal mice and rabbits by the usual parenteral routes without evidence of toxicity (3, 4). In man, subcutaneous or intramuscular injections of M protein or streptococcal cell walls containing M protein have been innocuous (5). The present report is concerned with the production in mice and rats of renal lesions following intravenous injections of larger quantities of M protein.
intravenously with 0.5 ml volumes of M protein or human serum albumin ~ (HSA) solution; amounts are described with individual experiments. Sprague-Dawley rats weighing 100 to 150 gm were injected intravenously with M protein or HSA as described in the protocols.
Antisera.--Anti-Type 1 M protein antisera were obtained from 2 to 3 kg New Zealand white rabbits immunized in the following manner: a saline solution of M protein containing 10 mg/ml was emulsified with an equal volume of complete Freund's adjuvant (Difco Laboratories, Inc., Detroit). Rabbits were injected with 0.5 ml of emulsion into each of 4 sites in the axillae and groin areas. Two weeks later these injections were repeated. Four weeks after onset of immunization intradermal injections of 0.1 ml of a saline solution (10 mg/ml) of M protein into four sites on the back were performed every 3rd day for 4 injections. Animals were bled from the heart 9 days after the last injections; the serum was separated, dispensed in 2 ml amounts, and frozen at --20°C. Analysis of precipitation patterns obtained in agar by Ouchterlony technique (10) , revealed one strong and one weak precipitation line. A single absorption of serum with an equal volume of packed heterologous streptococcal cells (SF42) at 37°C for 1 hour and 24 hours at 4°C, resulted in loss of the weaker precipitation line. Absorbed antiserum failed to precipitate in eapillary tubes (11) with potent acid extracts of types 3, 6, 12, 18, and 25 streptococci.
Rabbit anti-mouse fibrinogen antibodies were prepared according to the method of Gitlin et al. (12) . Three hundred mice were decapitated and pooled blood collected with heparin (Organon, Inc., West Orange, New Jersey) in final concentration of 20 u.s.P, units/ml. Plasma was separated immediately and Cohn fraction I obtained by low temperature ethanol-water separation (13) . Mouse fibrin was prepared from fraction I (0.5 per cent) with bovine thrombin (0.1 unit/ml). Fibrin strands were wound around a glass rod as they formed. After 90 minutes the fibrin was stripped off a glass rod into a Waring blendor in which it was washed three times with 0.15 M NaC1, then twice with distilled water, and then twice again with 0.15 ~ NaC1. Fibrin was then teased into very small particles and suspended in washed aluminum hydroxide, 25 mg fibrin per milliliter of suspension. Rabbits were injected weekly subcutaneously with 25 mg of fibrin suspension distributed into four sites in the axillae and groin areas. After four injections the rabbits were rested for 3 weeks and then received two more weekly injections.
1., Kindly obtained from Dr. R. C. Lance field. a Obtained through the generosity of Merck, Sharp and Dohme Laboratories, West Point, Pennsylvania.
Obtained from the Communicable Disease Center Laboratories, Atlanta, Georgia. Lot RLA 50B, provided by the American National Red Cross.
Ten days after the last injection animals were bled by cardiac puncture and the serum separated, dispensed in 2 ml amounts, and frozen. Precipitin analysis of the rabbit antisera performed in agar by double diffusion Ouchterlony technique against normal pooled mouse plasma revealed a strong fibrinogen-antifibrinogen line, and four contaminating precipitin lines. Rabbit antisera were absorbed with mouse serum as follows: normal pooled mouse serum was lyophilized and redissolved in water in concentration of 5 mg/ml. To 10 ml of rabbit antiserum was added 0.1 ml of the mouse serum solution. After incubation at 37°C for I hour and at 4°C overnight, the antiserum was centrifuged at 4000 g for 30 minutes in the cold and the supernate decanted. Successive increments of mouse serum solution were added in like manner to avoid antigen excess and the formation of soluble complexes of any of the contaminating serum protein antigens. After 6 to 9 absorptions, the resulting rabbit antiserum failed to precipitate with further addition of mouse serum solution. Precipitin analysis of the absorbed antiserum versus mouse plasma revealed a strong fibrinogen-antifibrinogen line with a faint contaminating line believed to represent plasminogen-antiplasminogen precipitate. Most plasminogen in plasma remains with the clot; little is left in serum. The failure to absorb antiplasminogen antibodies is likely to be due to absence or very low levels of plasminogen antigen in the absorbing mouse serum solution.
Floursce~ Labeling of A~iscra.--The globulin fractions of absorbed rabbit anti-Type 1 M protein antiserum and rabbit anti-mouse fibrinogen antiserum were prepared by precipitation with ammonium sulfate to a final concentration of 1.6 M. The precipitates were washed with 2.0 M ammonium sulfate in distilled water, redissolved, and dialyzed versus 0.01 ~r phosphate buffer at pH 7.5. Labeling of globulin was carried out under conditions similar to those described by Goldstein et al. (14) , after initial purification by application to a DEAE-ceUulose column equilibrated with 0.01 M phosphate buffer, pH 7.5. Protein solutions were concentrated to 1 per cent and reaction adjusted to pH 9-9.5 by addition of 0.1 N NaOH. Crystalline fluoresceine isothincyanate (Baltimore Biological Laboratories, Baltimore) was dissolved in acetone (2 mg/ml), and added slowly over a 2-hour period to the protein solution with maintenance of pH 9-9.5 and constant stirring until 10 nag of fluorescein isothiocyanate per gm of protein had been added. After reaction was allowed to proceed for 8 hours rapid separation of fluorescent globulins from acetone and fluorescent dialyzables was obtained by passing the reaction mixture through sephadex G-50 columns equilibrated with 0.01 ~ phosphate buffer pH 7.5. The first fluorescent peak eluted contained both labeled and unlabeled protein in appropriate buffer for rechromatography on DEAE cellulose to remove non-fluorescent globulin molecules. The effluent was placed on a DEAE cellulose column equilibrated with 0.01 M phosphate buffer pH 7.5 and the elution begun with the same buffer. Fluorescent globulins were seen a/fixed to the top of the column and unlabeled protein was eluted. After the effluent ceased to contain appreciable amounts of 280 m# absorbing materials, the buffer was changed to 0.01 ~ phosphate in 0.08 ~¢ saline at pH 7.5. With a Wood's lamp, a fluorescent peak could be seen to separate from the top of the column, travel down, and was collected and labeled preparation 1. Buffer was again changed to 0.01 M phosphate in 0.13 M saline at pH 7.5 and another peak was seen to separate from the top of the column~ travel down, and was collected and labeled preparation 2.
With this method both non-labeled globulin which blocks specific staining, and heavily labeled globulin which causes non-specific staining, are removed. It was not necessary to absorb these preparations with liver powders.
Fixation and Staining of Sections.--Organs to be examined by immunofluorescence were removed, quick frozen at --70°C within I0 minutes after death, and stored in sealed containers at --20°C until frozen sections were prepared. Routinely, sections were obtained from kidney, heart, lung, spleen, and liver. Unfixed frozen tissues were cut at a thickness of 5 micra in a eryostat. Sections were fixed by immersion in acetone at room temperatures for 30 minutes and dried in an incubator at 37°C for 30 minutes. Fixation of tissues in alcohol resulted in loss of M protein by dissolution as previously reported by Kaplan (4) . To a dry section, one drop of purified labeled antibody preparation was added and a slide placed in a moist chamber for 45 minutes at 37°C. The sections were then washed with three changes of 0.01 M phosphate buffer in saline, pH 7.2, for 5 minutes with gentle agitation on a shaking machine. Excess saline buffer was removed and slides mounted with glycerol buffer.
I-Iistologic sections were also prepared from organs fixed in 10 per cent buffered formalin within 10 minutes after sacrifice of the animals, and routinely stained with hematoxylin and eosin. In some cases Masson's trichrome and periodic acid-Schiff (PAS) stains were employed.
Specif~ity of Staining.--Controls of specificity of staining with anti-M conjugates consisted of the following tests: (a) conjugates were completely absorbed with homologous partially purified M protein; (b) fluorescent staining was inhibited by prior treatment of slides with unlabeled homologous specific antiserum; and (c) prior treatment with heterologous typespecific antisera failed to inhibit fluorescent staining of sections.
-The following criteria were met to control specificity of staining with antifibrinogen conjugates: (a) conjugates were completely absorbed with mouse plasma fraction 1; (b) fluorescent staining was inhibited by prior treatment of sections with unlabeled absorbed antifibrinogen antisera; and (c) fluorescent staining was not inhibited by prior treatment of sections with goat anti-mouse serum antiserum (Hyland Laboratories, Los Angeles, Lot G89).
Microscopy and Pkotograpky.--The Zeiss photomicroscopy was equipped with an Osram
HBO 200 ultraviolet light source, a BG12 exciter filter and a 530 m# barrier filter. Photographs were made in color with super anscochrome film, daylight type, and in black and white with adox KB14 film.
Chemical Determinations.--Blood urea nitrogen determinations 6 were performed by the method of Seligson and Seligson (15) , upon samples, obtained by puncture of the retroorbital sinus, which were anficoagulated with heparin, 30 v.s.P, unit/ml. Urinary protein determinations were performed on samples obtained from rats placed in metabolic cages and collected for 18 hours each day from 5 P,J to 11 AM during which time animals drank water ad libitum but food was removed. Urines were precipitated with 10 per cent trielfloracetic acid (TCA). The precipitate was washed twice with 10 per cent TCA and protein determined by the Lowry modification of the Folin-Ciocalteu method using human serum albumin standards (16) .
RESULTS
Mice were injected intravenously three times within 24 hours with 5 mg per injection of Type 1 M protein. Examination of the organs 24 hours after the last injection revealed lesions in all experimental animals. The pleural space contained serosanguineous fluid and hemorrhagic areas were noted over the surface of both lungs. The heart, liver, and spleen were grossly normal. Both kidneys appeared swollen, pale, and bloodless. Histologic sections of the organs revealed several hemorrhagic infarcts of the lungs and occasionally an eosinophilic mass was seen to be occluding a pulmonary vessel (Fig. 1) . Striking lesions were seen in all sections of the kidneys. Glomeruli were swollen, almost filling Bowman's space, and the glomerular capillary bed was completely occluded by an eosinophilic amorphous fibrin-like material, shown in Fig. 2 . The inflammatory reaction accompanying these striking lesions was slight with occasional polymorphonuclear leukocytes and small areas of necrosis. The tubules were seen to contain proteinaceous material within the lumina but were 6 Kindly performed under the direction of Dr. David Seligson. not abnormal. Occasional eosinophilic masses were seen in the spleen and in Kupffer's ceils within the liver. Organs of control mice injected with comparable amounts of human serum albumin were grossly and microscopically normal when examined at intervals from 24 hours to 14 days. A kidney section from a control mouse, shown in Fig. 3 , was obtained 24 hours after three injections of 5 mg of HSA; the capillary loops are delicate and contain red blood cells.
Subsequent experiments with single intravenous injections of varying amounts of M protein established a threshold of 3 mg at which renal lesions became evident. Ten mice were injected with 3.0 mg of Type I M protein and sacrificed in pairs at 1, 2, 4, 8, and 14 days after injection. Sections from these animals revealed lesions only in the kidneys, which were less severe than seen previously but were present in nearly all gomeruli. A typical section is shown in Fig. 4 . The same type of eosinophilic fibrin-like material is seen in portions of the glomerulus. Again the inflammatory reaction is slight and necrosis is limited to a rare involved area. Glomerular lesions regressed and disappeared within 14 days. At 3 days the foreign material is still evident (Fig. 5) ; it became difficult to find at 8 days and sections taken at 14 days were indistinguishable from controls.
To determine the nature of the material within the glomerular capillary loops, adjacent 5 micra frozen sections were cut from a kidney removed 24 hours after the mouse received 8.0 mg of Type 1 M protein intravenously. The first section was stained with fluorescent anti-Type 1 M protein antibodies; the next section was stained with hematoxylin and eosin, and the third section was prepared with fluorescent anti mouse fibrinogen. Figs. 6 a to 6 c, demonstrate that the eosinophilic material occluding the capillary lumina contains both M protein and fibrinogen.
To correlate structural anomalies with changes in renal function, SpragueDawley rats were intravenously injected with Type 1 M protein (0.1 mg per gm of body weight). They were placed in metabolic cages from which urine was collected daily, examined microscopically, and tested for protein. Rats were bled by retroorbital sinus puncture performed under light ether anesthesia every 2 days, and blood-urea-nitrogen levels determined. Two rats were sacrificed on day 1, 3, 6, 9, 12, 16, and 23 after M protein injection; organs were fixed in formalin and prepared for histologic section. Examination of heart, liver, lung, and spleen sections revealed no abnormalities. Glomerular lesions similar in all respects to these observed in mice were noted. A typical rat glomerulus in a section obtained after M protein injection is illustrated in Fig. 7 and may be compared to a section from a control rat injected with HSA (0.15 mg per gm of body weight) shown in Fig. 8 . During the first week after M protein injection, progressive resolution of glomeruli lesions was apparent. Although small residua of M-fibrinogen thrombi were recognizable until the 3rd week, no interruption in the gradual improvement of glomerular lesions were noted. However, even after recognizable thrombi could not be seen, fine walled glomerular capillaries were not common and capillary loops appeared separated by diffuse material (Fig. 9) . Control rat kidneys never demonstrated significant lesions.
Urinary protein excretion of rats injected with M protein increased when compared to controls injected with HSA. The highest daily protein output of any control rat was 5 mg (Text-fig. 1 ). On the 1st day after M protein injection 9 of 26 experimental rats excreted protein in excess of 5 rag/day; in addition capillary precipitation tests with type-specific antiserum revealed M protein in 20 to 26 urines from experimental rats. The number of rats demonstrating abnormal proteinuria and the degree of abnormality decreased during the 1st week, so that on the 7th and 8th days protein excretion of the experimental group was comparable to that of controls. An increase during the 2nd week in daily proteinuria of some rats in the experimental group was noted; 6 of the 26 experimental rats excreted ~ 5.0 rag/day of protein on days 9 and 10. By the end of the 2nd week both groups were again excreting comparable amounts of protein. Microscopic examination of the urinary sediments revealed occasional casts in the experimental group, but red blood cells or red blood cell casts were never seen.
Elevation of blood urea nitrogen levels in 12 of the 26 experimental rats were noted on the 3rd day following injection of M protein (Text- fig. 2 ). It should be pointed out that both groups were comparable when assayed 24 hours after injection. On the 5th day 7 rats in the experimental group had BUN levels above 30 mg per cent, and on subsequent days levels in experimental animals fell within control range. However, on the llth day, 2, and the 13th day, 6 experimental rats showed modest elevations in BUN. This second rise in BUN levels followed the rise in urinary protein levels by 1 to 2 days as did the first elevation of BUN levels.
Capillary precipitin tests performed on rat sera obtained during the experiment with Type 1 M protein (0.1 mg/ml) demonstrated appearance of anti-M antibodies on the 9th day in 20 to 26 experimental animals, including all animalswith abnormal proteinuria or azotemia. Two more rats demonstrated serum anti-M antibodies on the llth day after antigen injection. A typical series of precipitin tests on sera from one rat is plotted above the BUN data in Text- fig. 2 .
Review of histologic sections obtained during the early period of the 2nd week after M protein injection failed to reveal increased cellularity, inflammation, or necrosis to correlate with the observed functional changes.
DISCUSSION
The injection of 0.1 mg per gm of body weight of Type 1 M protein into mice or rats produced a nephropathy characterized by diffuse eosinophilic glomerular lesions shown to contain streptococcal M protein and fibrinogen. The rapidity with which M protein reacted with fibrinogen in vitro (17) , suggests that com- plexes were formed intravascularly and then became localized within the glomerular capillary bed. Previous workers have demonstrated the propensity of intravenously injected M protein to localize and persist only in the glomerular tufts. Although the 0.5 to 1.0 mg amounts injected in their studies were not sufficient to produce visible lesions, M protein was detected in glomeruli 4 to 8 days after injection by Kaplan (4) and 16 days after injection by Miller (18) . M protein appeared as discrete deposits varying from small particles to large globularmasses. Presumably, the unusual distribution of M protein, confined as it was, largely within the reticuloendothelial system (RES) and kidney (4), was related to its association with fibrinogen forming a macromolecular complex. An important question is why M-fibrinogen complexes localize in glomeruli; large macromolecules are usually cleared by the RES. Colloidal preparations, such as carbon, ordinarily cleared by the RES, may under certain conditions of prolonged high blood levels, or endothelial damage, localize outside the RES (19) . In such situations glomeruli generally show striking accumulation of par. ticles. Glomerular damage, as a consequence of retention of circulating colloidal material, has been reported after intravenous injection of methyl cellulose and saccharated iron oxide (20, 21) .
The histologic picture of the mouse and rat nephropathy produced by injection of Type I streptococcal M protein does not resemble human acute diffuse glomerulonephritis. No hypercellularity and little inflammatory reaction or necrosis was demonstrated. The nephropathy differs also from that usually produced by antigen-antibody complexes. However, the present renal lesions are indistinguishable from glomerular lesions seen in the generalized Shwartzman reaction and those produced by antigen-antibody complexes in animals pretreated with cortisone (22, 23) . All three experimental lesions are believed to contain fibrinogen or fibrin, and the similarities of structure may only reflect aggregation of fibrinogen by endotoxin, by antigen-antibody complexes, and by streptococcal M protein in the respective experimental models.
Proteinuria and urea retention observed after injection of M protein are consistent with the morphological glomerular lesions. However, the reappearance of proteinuria and mild azotemia in some rats during the 2nd week coincident with appearance of circulating anti-M antibodies was not accompanied by discernible glomerular changes. The persistance of M protein within the glomeruli during this period was reported by Miller, who injected considerably less M protein (18) . Previous studies have shown that localization of an antigen within the kidney may lead to glomerulonephritis when antibodies develop to that antigen. Kay (24) , injected duck anti-rabbit kidney serm~ into rabbits but did not observe nephritis until anti-duck serum antibodies appeared. Similar results were reported by Rothbard and Watson (25) who injected rats with rabbit anti-rat collagen antiserum and observed nephritis only when rats were prepared with adjuvant and developed anti-rabbit serum antibodies. In both described in-instances, the antigen implicated in the nephritis was first localized in the kidney by viture of its properties as an antibody directed against kidney tissue.
In the present experiments, a different mechanism for the localization of a streptococcal product within the kidney has been demonstrated. Whether the complex of M protein and fibrinogen, localized and concentrated within the glomerulus can stimulate an immune response, thereby inflating glomerulonephriffs, is unknown. Seegal has recently reported the presence of streptococcal M protein in renal glomeruli obtained by biopsy of patients with acute glomerulonephritis (26). Stetson et al. (27) have observed significant hematuria during the acute streptococcal infection which was prognostic of later development of nephritis. Data presented above raise the suggestion that intravascular formation of M-fibrinogen complexes may cause localization of M antigen in the human kidneys resulting in mild early hematuria. With development of hypersensitivity directed against previously localized, persistent M protein, the immunologic reaction would result in acute glomerulonephritis. This suggestion presumes that fibfinogen will be present in the glomerulus sometime between the onset of infection and the appearance of nephritis. Opportunity to verify this possibility may be provided by examination of human renal tissue which has been obtained at the proper time by percutaneous needle biopsy, by surgical biospy, or by autopsy.
SUMMARY
Intravenous injection of Type I streptococcal M protein into mice and rats producedlesions confined to renal glomeruli. Thrombi of eosinophilic amorphous material, seen to occlude glomerular capillaries, were shown to contain M protein and fibrinogen. Gradual regression of the morphological lesions was observed during the 3 weeks following injection. Initial abnormal proteinuria and azotemia returned to control levels by the end of the 1st week; a second rise in urinary protein excretion and urea retention was demonstrated in some rats coincident with appearance of anti-M antibodies. The mechanism of renal localization of streptococcal M protein by means of a complex with fibrinogen was suggested, which may comprise an initial phase in the pathogenesis of acute poststreptococcal glomerulonephritis. 
